In-vitro activity of three brands of ceftriaxone against different clinical isolates

Journal of the Nepal Medical Association

Volumn 49, Issue 3, 2010, Pages 225-227

  Thapa, Badri ^a   Mahat, K ^b  

^a KATHMANDU MEDICAL COLLEGE   (Nepal)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Agar dilution; Ceftriaxone brands; Multi drug resistant

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALOTIN; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; KANAMYCIN; NETILMICIN; NORFLOXACIN; PIPERACILLIN; ANTIINFECTIVE AGENT;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISK DIFFUSION; DRUG DOSAGE FORM COMPARISON; ESCHERICHIA COLI; IN VITRO STUDY; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NEPAL; NONHUMAN; PROTEUS; STAPHYLOCOCCUS AUREUS; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION;

ANTI-BACTERIAL AGENTS; CEFTRIAXONE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS; NEPAL; PROTEUS; STAPHYLOCOCCUS AUREUS;

EID: 84856377448     PISSN: 00282715     EISSN: None     Source Type: Journal    
DOI: 10.31729/jnma.93     Document Type: Article

References (11)

1. Axelrod JL, Newton JC, Sarakhun C, et al. Ceftriaxone a new cephalosporin with aqueous humor levels effective against Enterobacteriaceae. Arch Ophthamol. 1985;103:71-2.
2. Acharya G, C Crevoisier, T Butler, et al. Pharmacokinetics of ceftriaxone in patients with typhoid fever. Antimicrob Agents Chemother. 1994;38:2415-8.
3. Smith MD, Duong NM, Hoa NTT, et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob Agents Chemother. 1994;38:1716-20.
4. Sharma N, Koju R, Karmacharya B, et al. Typhoid fever in Dhulikhel Hospital, Nepal. Kathmandu Univ Med J. 2003;2:188-92.
5. Shankar PR, Partha P, Dubey AK, Mishra P, Deshpande VY. Intensive care unit drug utilization in a teaching hospital in Nepal. Kathamandu Univ Med J. 2005;3:130-7.
6. Neopane A, Singh SB, Bhatta R, Dhital B, Karki DB. Changing spectrum of antibiotic sensitivity in enteric fever. Kathamandu Univ Med J. 2008;6:12-5.
7. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. NCCLS document M100-S15, Fifteenth Informational Supplement. 25th ed. USA: Clinical Laboratory Standards Institute. 2005.
8. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48:5-16.
9. Malla S. Salmonella infection and antimicrobial resistance trend in Nepal. Meeting on typhoid fever vaccination in the Asia pacific region. Bangkok, Thailand: 2009.
10. Paul DF, Safranek TJ, Rupp ME, et al. Ceftriaxone-resistant salmonella infection acquired by a child from cattle. New Engl J Med. 2000;342:1242-9.
11. Yan JJ, Ko WC, Tsai SH, Wu HM, Jin YT, Wu JJ. Dissemination of CTX-M-3 and CMY-2 ß-Lactamases among clinical isolates of Escherichia coli in Southern Taiwan. J Clin Microbiol. 2000;38:4320-25.